Pharma and Biotech
Period Ending | Period | Revenue (£m) | Pre-tax (£m) | EPS | Dividend |
---|---|---|---|---|---|
30-Sep-23 | Interim | 0.08 | (1.57) | (0.56)p | n/a |
Year Ending | Revenue (£m) | Pre-tax (£m) | EPS | P/E | PEG | EPS Grth. | Div | Yield |
---|---|---|---|---|---|---|---|---|
31-Mar-19 | n/a | (0.63) | (0.54)p | n/a | n/a | n/a | n/a | 0.0% |
31-Mar-20 | 0.09 | (1.85) | (1.27)p | n/a | n/a | n/a | n/a | 0.0% |
31-Mar-21 | 0.32 | (5.90) | (3.05)p | n/a | n/a | n/a | n/a | 0.0% |
31-Mar-22 | 0.62 | (5.57) | (2.65)p | n/a | n/a | n/a | n/a | 0.0% |
31-Mar-23 | 0.83 | (4.26) | (1.75)p | n/a | n/a | n/a | n/a | 0.0% |
a. Based on UK GAAP presentation of accounts - includes discontinued activities
Forecasts data is not available for this company.
Copyright © 2024 FactSet Research Systems Inc. All rights reserved.
5 Yr High | 5 Yr Low | 5 Yr Avg | Curr / Avg | |
---|---|---|---|---|
Latest | n/a | n/a | n/a | 0 |
Find out about IFRS and how this affects the financial infomation for all UK companies.
Currency | UK Pounds |
Share Price | 2.35p |
Change Today | -0.050p |
% Change | -2.08 % |
52 Week High | 2.50 |
52 Week Low | 2.10 |
Volume | 2,008,464 |
Shares Issued | 506.29m |
Market Cap | £11.90m |
Value |
---|
Value |
---|
Income |
---|
Growth |
---|
No dividends found |
Time | Volume / Share Price |
13:44 | 354 @ 2.40p |
13:44 | 50,000 @ 2.30p |
13:41 | 60,000 @ 2.34p |
13:39 | 140,434 @ 2.37p |
13:36 | 60,000 @ 2.36p |
You are here: research